Oral administration is possible in preclinical research
Dosage Forms and Strengths: L-Carnitine Injection is available as a sterile solution in vials or ampules for parenteral administration
It is important to note that there is currently no single model that can accurately reflect the heterogeneity of human TBI, and in each of these models, pathologic and neurologic outcomes vary according to the severity and location of the insult and heterogeneity of the vasculature
This work was supported by grants from the National Natural Science Foundation of China (32270727, 32000141), the Natural Science Foundation of Fujian Province (2021J01029) and the Fundamental Research Funds for the Central Universities (20720210094) to Y.C., grants from the Research Grants Council of Hong Kong (CRS_CUHK405/23, AoE/M-402/25-N, AoE/M-05/12, CUHK14106823, C4033-19E, C4002-20W, C4002-21EF, C2003-22WF, R4005-18, C4014-23G, G-CUHK409/23 and Senior Research Fellow Scheme SRFS2122-4S01), the Chinese University of Hong Kong (CUHK) Research Committee, and Science Faculty to L.J., as well as grants from the State Key Laboratory of Chemical Biology and Drug Discovery (PolyU), the Research Grants Council (RGC) (Hong Kong) (14105517) and the Hong Kong Polytechnic University (University Grants Committee) (P0046618) to W.C.Y.L
